WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Thomas HendersonChief Executive Officer2026-05-1318,659$82.05
$1.53MSell
Michael Thomas HendersonChief Executive Officer2026-05-131,341$82.58
$110.74kSell
Carl DambkowskiChief Medical Officer2026-05-063,700$83.92
$310.50kSell
Carl DambkowskiChief Medical Officer2026-05-061,800$84.60
$152.28kSell
Carl DambkowskiChief Medical Officer2026-05-064,125$22.86
$94.30kBuy
Jane HendersonChief Financial Officer2026-05-01900$82.60
$74.34kSell
Jane HendersonChief Financial Officer2026-05-01289$83.16
$24.03kSell
Jane HendersonChief Financial Officer2026-05-01811$81.02
$65.71kSell
Jane HendersonChief Financial Officer2026-04-162,000$90.00
$180.00kSell
Michael Thomas HendersonChief Executive Officer2026-04-163,000$22.86
$68.58kBuy

1 of 9

APGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc13.66%10,300,984$811.20MInstitution
Fmr LLC12.29%9,262,291$729.41MInstitution
Venrock Adviser LLC11.27%8,493,321$668.85MInstitution
Wellington Management Group LLP5.80%4,375,703$344.59MInstitution
Blackrock Inc5.42%4,085,651$321.75MInstitution
Rtw Investments LP3.69%2,782,097$219.09MInstitution
Vanguard Capital Management LLC3.32%2,502,095$197.04MInstitution
Janus Henderson Group PLC3.13%2,360,596$185.90MInstitution
State Street Corp2.87%2,162,964$170.33MInstitution
Driehaus Capital Management LLC2.55%1,920,800$151.26MInstitution

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE95.49%4.51%Net SellingNet Selling
MIRM56.43%43.57%Net BuyingNet Selling
PTCT86.90%13.10%Net SellingNet Selling
RYTM88.74%11.26%Net SellingNet Buying
SYRE76.39%23.61%Net SellingNet Selling
View Top Biotech Stocks

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 104.86% institutional shareholders, 4.96% Apogee Therapeutics insiders, and 0.00% retail investors. Nimish P. Shah is the largest individual Apogee Therapeutics shareholder, owning 1.75M shares representing 2.32% of the company. Nimish P. Shah's Apogee Therapeutics shares are currently valued at $136.97M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.